BrdU Mouse Monoclonal Antibody [Clone ID: OTI2B5]
CAT#: TA190219
BrdU mouse monoclonal antibody, clone OTI2B5 (formerly 2B5)
Formulation: Carrier-Free
View other "OTI2B5" antibodies (2)
Need it in bulk or conjugated?
Get a free quote
CNY 1,999.00
CNY 2,840.00
Cited in 2 publications. |
Specifications
Product Data | |
Clone Name | OTI2B5 |
Applications | FC, IF, IHC |
Recommend Dilution | IHC 1:150, IF 1:150 |
Host | Mouse |
Clonality | Monoclonal |
Immunogen | Bromodeoxyuridine coupled to keyhole limpet hemocyanin (KLH). |
Formulation | PBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide. |
Concentration | 1 mg/ml |
Purification | Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G) |
Conjugation | Unconjugated |
Storage Condition | Store at -20°C as received. |
Note | 5-chloro-2'-deoxyuridine (ClDU), 5-bromo-2'-deoxyuridine (BrdU), 5-iodo-2'-deoxyuridine (IdU) and 5-ethynyl-2'-deoxyuridine (EdU) are nucleoside analogs of thymidine. Cells that treated with these analogs will incorporate the chemicals into the genomic DNA during S-phase. Immunochemical method detection of these analogs is thus used to quantify the cell proliferation, cell cycle status in vitro or in vivo. Since the thymidine analogs can be passed onto the daughter cells, they can also used to trace dividing cell fate in a short period of time over 3 generations. In addition, combination of different analogs and their specific antibodies can be used to trace cell fate in different time frames. |
Reference Data |
Citations (2)
The use of this Antibodies has been cited in the following citations: |
---|
p120-catenin suppresses proliferation and tumor growth of oral squamous cell carcinoma via inhibiting nuclear phospholipase C-γ1 signaling
,Li, L;Ji, S;Shrestha, C;Jiang, Y;Liao, L;Xu, F;Liu, Z;Bikle, DD;Xie, Z;,
J. Cell. Physiol.
,PubMed ID 32356317
[BRDU]
|
Icariin and mesenchymal stem cells synergistically promote angiogenesis and neurogenesis after cerebral ischemia via PI3K and ERK1/2 pathways
,Liu, D;Ye, Y;Xu, L;Yuan, W;Zhang, Q;,
Biomed. Pharmacother.
,PubMed ID 30245466
[BRDU]
|
Documents
Product Manuals |
FAQs |
SDS |
Resources
抗体相关资料 |